期刊文献+

血管紧张素原基因-20A/C多态性与2型糖尿病肾病相关性研究 被引量:2

Study on relationship between-20A/C angiotensinogen gene polymorphisms and diabetic nephropathy of T2DM patients
原文传递
导出
摘要 目的探讨血管紧张素原(AGT)基因-20A/C多态性与DN关系。方法应用聚合酶链反应-限制性片段长度多态性分析法(PCR-RFLP)对292例T2DM患者(正常白蛋白尿组148例,微量白蛋白尿组105例,大量白蛋白尿组39例)及157名正常对照(NC)者进行AGT基因-20A/C多态性检测。结果男性大量白蛋白尿组等位基因C频率高于正常白蛋白尿组(P=0.046)。Logistic回归分析显示,携带等位基因C(OR:4.268,P=0.043,95%CI:1.044~17.447)与男性大量白蛋白尿相关。结论 AGT基因-20A/C多态性可能与浙江地区汉族人群男性T2DM患者出现大量白蛋白尿相关。 Objective To investigate the relationship between angiotensinogen(AGT) gene-20A/C polymorphism and the susceptibility to type 2 diabetic nephropathy.Methods Using polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP) to detect AGT gene-20A/C polymorphisms in 292 patients with T2DM(148 in normo-albuminuria group,105 in micro-albuminuria group,and 39 in macro-albuminuria group) and 157 normal controls(NC).Results In the male macro-albuminuria group,the frequency of C allele was significantly higher than in the normo-albuminuria group(P=0.046).The AGT gene-20A/C polymorphism(OR: 4.268,P=0.043,95%CI: 1.044~17.447) was an independent risk factor for macro-albuminuria in male patients.Conclusion AGT gene-20A/C polymorphism might be a susceptibility gene for macro-albuminuria in male T2DM patients in Zhejiang Han population.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2013年第2期113-117,共5页 Chinese Journal of Diabetes
基金 浙江省重大科技专项重点社会发展项目(2009C0310-4) 国家科技支撑计划(2009BAI80B01)
关键词 糖尿病 2型 糖尿病性肾脏疾病 血管紧张素原基因 基因多态性 Diabetes mellitus type 2 Diabetic nephropathy Angiotensinogen gene Gene polymorphism
  • 相关文献

参考文献6

  • 1Cynthia CW, Naomi D, et al. Genetic Polymorphisms and theRisk of Accelerated Renal Function Decline in Women. PlosOne, 2009,4:e4787.
  • 2Narita I, Goto S,et al. Genetic polymorphism in angiotensino-gen promotor region affects progression of IgA nephropathy.Nephrology, 2001?6 : A26-A27.
  • 3全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:702
  • 4National Kidney Foundation. K/DOQI clinical practice guide-lines for chronic kidney disease, evaluation, classification, andstratification. Am J Kidney Dis, 2002,39:S1-S266.
  • 5Liu KP, Lin CY, et al. Renin-angiotensin system polymor-phisms in Taiwan Residents primary vesicoureteral reflux. PediatrNephrol, 2004,19:594-601.
  • 6Narita I, Goto S,et al. Angiotensinogen gene variation andrenoprotective efficacy of renin-angiotensin system blockade inIgA nephropathy. Kidney Int, 2003,64: 1050-1058.

二级参考文献21

  • 1Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem, 1992,38 : 1933-1953.
  • 2Giovannetti S, Barsotti G. In defense of creatinine clearance.Nephron, 1991,59: 11-14.
  • 3Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med,1999,130:461-470.
  • 4Levey AS, Greene T, Kusek J, et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol, 2000, 11 : A0828 (abstract).
  • 5Eknoyaa G, Levin N. NKF-K/DOQI Clinical Practice Guidelines: Update 2000. Foreword. Am J Kidney Dis,2001, 37 (1 Suppl 1):S5-S6. Erratum in: Am J KidneyDis, 2001,38:917.
  • 6Zuo L, Ma YC, Zhou YH, et al. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am .I Kidney Dis, 2005, 45:463-472.
  • 7Blaufox MD, Aurell M, Bubeck B, et al. Report of the Radionuclides in Nephrourology Committee on renal clearance.J Nucl Med, 1996, 37:1883-1890.
  • 8Chantler C, Barratt TM. Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid. Arch Dis Child, 1972, 47:613-617.
  • 9Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known.1916. Nutrition, 1989,5 : 303-311.
  • 10Duan N.Smearing estimate:a nonparametric retransformation method. Journal of the American Statistical Association,1983, 78 : 605-610.

共引文献701

同被引文献18

  • 1王袁,吴琪俊,施榕.糖尿病肾病与载脂蛋白E基因多态性相关性的Meta分析[J].上海交通大学学报(医学版),2011,31(5):625-631. 被引量:9
  • 2Gordin D, Forsblom C, Panduru NM,et al.Osteopontin is a strong predictor of incipient diabetic nephropathy,cardio- vascular disease,and all-cause mortality in patients with type 1 diabetes[J].Diabetes Care,2014,37(9):2593-2600.
  • 3傅明捷,黄萍,王艳,等.糖尿病肾病患者蛋白尿与C反应蛋白、肿瘤坏死因子-α和白介素-6水平关系的临床研究[J].中国医药导报,2013,10(15):89-90.
  • 4Mori J, Patel VB, Ramprasath T,et al.Angiotensin 1-7 me- diates renoprotection against diabetic nephropathy by re- ducing oxidative stress,inflammation,and lipotoxicity [J]. Am J Physiol Renal Physiol,2014,306(8):F812-F821.
  • 5Kwakernaak AJ,Krikken JA,Binnenmars SH,et al.Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy:a randomised clinical trial[J].Lancet Diabetes Endocrinol, 2014,2 (5) :385- 395.
  • 6Berezin AE,Kremzer AA.Circulating osteopontin as a mark- er of early coronary vascular calcification in type two dia- betes mellitus patients with known asymptomatic coronary artery disease[J].Atherosclerosis, 2013,229 (2) : 475 -481.
  • 7Heuer JG,Breyer MD.Osteopontin in diabetic nephropa- thy: signpost or road?[J].Kidney Int,2010,77 (7) : 565-566.
  • 8郑劲松.肾结石患者尿沉渣中骨桥蛋白检测的意义[J].中国当代医药,2010,17(21):91-93. 被引量:1
  • 9刘丽梅,项坤三,郑泰山.醛糖还原酶基因多态性与糖尿病微血管并发症的相关性研究[J].中华内分泌代谢杂志,1999,15(5):263-266. 被引量:16
  • 10范静静,张晓梅.血浆内脂素、一氧化氮与2型糖尿病及糖尿病肾病的关系研究[J].蚌埠医学院学报,2012,37(3):267-270. 被引量:3

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部